Impact BioMedical, Inc. (IBO) — Cash Flow Quality Index
Latest as of September 2024:
-0.30x
Impact BioMedical, Inc. (IBO) has a Cash Flow Quality Index of -0.30x as of September 2024. Operating cash flow of $-1.74 Million is below net income of $5.74 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Impact BioMedical, Inc. (IBO) investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
-0.30x
Operating CF / Net Income
Operating Cash Flow
$-1.74 Million
USD
Net Income
$5.74 Million
USD
Data as of
Sep 2024
Most recent filing
Annual Cash Flow Quality Index for Impact BioMedical, Inc. (None–None)
Year-by-year earnings quality comparison for Impact BioMedical, Inc.. For live market cap and the full company financial profile, see Impact BioMedical, Inc. market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.